PRINCIPAL FINANCIAL GROUP INC
Position in DNLI — Denali Therapeutics Inc.
CIK 1126328
DES MOINES, IA
Position in DNLI
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$36,524,534
+$8,137,604 QoQ
Shares Held
1,420,083
-4.0% QoQ
Ownership
0.888%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. DNLI ranks #14 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,524,534 | 1,420,083 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $28,386,930 | 1,478,486 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $25,163,270 | 1,524,123 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $18,457,678 | 1,271,190 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $15,011,031 | 1,072,983 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $14,704,051 | 1,081,578 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $23,049,025 | 1,130,963 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $36,076,804 | 1,238,476 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $25,275,828 | 1,088,537 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $23,034,438 | 1,122,536 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $23,041,686 | 1,073,704 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $14,030,008 | 680,078 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $20,258,378 | 686,492 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $11,265,660 | 488,961 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $14,640,824 | 526,459 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $16,752,780 | 545,871 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $7,879,352 | 267,732 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $8,653,858 | 269,004 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $14,730,264 | 330,275 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $15,328,071 | 303,827 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $25,833,743 | 329,344 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $19,275,075 | 337,567 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $17,380,534 | 207,504 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $7,257,186 | 202,545 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $4,884,891 | 202,022 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $3,576,470 | 204,253 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||